Novel treatment strategies for depression in patients with hepatitis C.
Loftis
Jennifer M
JM
Turner
Erick H
EH
D006916:5-Hydroxytryptophan / Q000378:metabolism / Q000627:therapeutic use; D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000378:metabolism / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000009:adverse effects*; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D003865:Major Depressive Disorder / Q000139:chemically induced* / Q000188:drug therapy / Q000378:metabolism; D019587:Dietary Supplements; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014364:Tryptophan / Q000378:metabolism / Q000627:therapeutic use*
D018687:Antidepressive Agents, Second-Generation; D000998:Antiviral Agents; D016898:Interferon-alpha; D012701:Serotonin; D014364:Tryptophan; D006916:5-Hydroxytryptophan